Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cardiol Therapeutics Inc
T.CRDL
Alternate Symbol(s):
CRDL
Healthcare
Cardiol Therapeutics Inc. is a clinical-stage life sciences company. The Company is focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead drug candidate, CardiolRx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is...
recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. It is also developing CRD-38, a novel subcutaneously administered drug intended for use in heart failure. It has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CRDL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(23)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on May 16, 2024 9:55am
Day of rest!
Very low volume so far today.
(1592)
•••
Possibleidiot01
X
View Profile
View Bullboard History
Post by
Possibleidiot01
on Apr 14, 2024 7:08am
from stockhouse front page
BASF and Cardiol Therapeutics recommended buys; TUI rides momentum Fabian Lorenz, Apaton 0 Comments| 3 days ago
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 21, 2024 7:28am
New Press Release - Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
Topline Results Expected in Q2 2024This is a Designated News Release.Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a clinical-stage life sciences company focused on the research and clinical development...
read article.
(23)
•••
Alim33
X
View Profile
View Bullboard History
Comment by
Alim33
on Feb 20, 2024 5:40pm
RE:RE:Financing?
Thanks.
(1)
•••
WHATSUPBOB34344
X
View Profile
View Bullboard History
Comment by
WHATSUPBOB34344
on Feb 20, 2024 4:37pm
RE:Financing?
They Have 40 million fully funded till 2026
(23)
•••
Alim33
X
View Profile
View Bullboard History
Post by
Alim33
on Feb 20, 2024 2:44pm
Financing?
Question for those who might know, does this company requires financing soon? Last was in 2021.
(20)
•••
GoGoUpUp
X
View Profile
View Bullboard History
Post by
GoGoUpUp
on Feb 15, 2024 5:57pm
Time to Fly 🚀 🚀🚀 $$$ FDA $$$
This will be one if not the best stock in your profolio 2024 congrats to everyone that got in early
(98)
•••
whytestocks
X
View Profile
View Bullboard History
Post by
whytestocks
on Feb 15, 2024 2:45pm
Orphan Drug Designation Sends Shares of this Dual-Listed Lif
BREAKING NEWS: $CRDL Orphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring2024-02-15 14:25:53 ET %OrphanDrug designation, or ODD, is valuable on both a
...more
(32)
•••
satchmo6
X
View Profile
View Bullboard History
Post by
satchmo6
on Sep 26, 2023 12:50pm
Rosewood Hotel
only 600.00 for a room fitzgerald suite is less...patrick fits gerald and gerald ...goes home
(116)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Jun 07, 2023 12:27pm
It's gonna run soon.
Technical Analysis for CRDL 1 minute1 minute5 minutes5 minutes15 minutes15 minutes30 minutes30 minutes1 hour1 hour2 hours2 hours4 hours4 hours1 day1 day1 week1 week1 month1 monthMoreMore
...more
(116)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Jun 06, 2023 11:42am
Financially healthy also
Return vs Industry: CRDL exceeded the Canadian Pharmaceuticals industry which returned -55.8% over the past year.
(116)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Jun 06, 2023 11:37am
In again
You should never fall in love with stocks but Crdl is one of my faves and at this price it is a steal imo
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on May 24, 2023 11:02pm
CBD Study Dr. Campbell
https://youtu.be/Bz4fn2QFO_A
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 25, 2023 9:29am
Cardiol Presentation - Undervalued Stock
https://youtu.be/ER9ke3YbFUU
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Feb 25, 2023 9:26am
Keep an Eye on this One
https://www.cantechletter.com/2022/12/cardiol-therapeutics-is-heading-to-4-50-says-leede-jones-gable/
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
GameSquare Announces Formation of FaZe Media, Backed by $11M Investment
Xcyte Digital Corp. Releases "Xperience" Subscription Service
Drilling Approval Received for New Mexico Lithium Project